The HS Scientific Strategy Lead will lead the commercial scientific strategy for the company's investigational monoclonal antibody tulisokibart in hidradenitis suppurativa (HS). The role translates complex science, clinical evidence and customer insight into a differentiated, credible scientific narrative, while ensuring that evidence generation and scientific engagement support the global commercial ambition, Phase 3 program and launch readiness. Working across Commercial, Medical Affairs, Clinical Development, Outcomes Research, Global Market Access, Policy and priority markets, the position will shape evidence priorities, scientific leader engagement, congress strategy and communications. It will also support early Dermatology pipeline and business development assessments, manage relevant agency relationships and budgets, and report progress, risks and recommendations to the Executive Director, Global Commercial Lead, Hidradenitis Suppurativa. The role is based in Rahway, New Jersey, with hybrid work arrangements and 25% travel.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director